Hanmi Science - Asset Resilience Ratio

Latest as of December 2025: 0.05%

Hanmi Science (008930) has an Asset Resilience Ratio of 0.05% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Hanmi Science for a breakdown of total debt and financial obligations.

Liquid Assets

₩783.60 Million
≈ $531.04K USD Cash + Short-term Investments

Total Assets

₩1.49 Trillion
≈ $1.01 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2000–2025)

This chart shows how Hanmi Science's Asset Resilience Ratio has changed over time. See Hanmi Science net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Hanmi Science's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Hanmi Science.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩783.60 Million 0.05%
Total Liquid Assets ₩783.60 Million 0.05%

Asset Resilience Insights

  • Limited Liquidity: Hanmi Science maintains only 0.05% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Hanmi Science Industry Peers by Asset Resilience Ratio

Compare Hanmi Science's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Sigma Healthcare Ltd
AU:SIG
Medical Distribution 0.03%
Cyclopharm Ltd
AU:CYC
Medical Distribution 1.98%
Ebos Group Ltd
AU:EBO
Medical Distribution 0.00%
Paragon Care Ltd
AU:PGC
Medical Distribution 0.00%
Mayne Pharma Group Ltd
AU:MYX
Medical Distribution 4.00%
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
Medical Distribution 4.48%
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
Medical Distribution 4.44%
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SHG:600332
Medical Distribution 5.56%

Annual Asset Resilience Ratio for Hanmi Science (2000–2025)

The table below shows the annual Asset Resilience Ratio data for Hanmi Science.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 0.05% ₩783.60 Million
≈ $531.04K
₩1.49 Trillion
≈ $1.01 Billion
-0.25pp
2024-12-31 0.30% ₩4.02 Billion
≈ $2.72 Million
₩1.35 Trillion
≈ $914.25 Million
-0.27pp
2023-12-31 0.57% ₩6.93 Billion
≈ $4.70 Million
₩1.23 Trillion
≈ $830.96 Million
+0.56pp
2022-12-31 0.01% ₩92.75 Million
≈ $62.86K
₩1.11 Trillion
≈ $752.02 Million
+0.00pp
2021-12-31 0.00% ₩38.55 Million
≈ $26.12K
₩949.89 Billion
≈ $643.73 Million
-0.02pp
2020-12-31 0.02% ₩177.73 Million
≈ $120.45K
₩923.22 Billion
≈ $625.65 Million
-0.02pp
2019-12-31 0.04% ₩363.98 Million
≈ $246.66K
₩910.83 Billion
≈ $617.26 Million
-0.54pp
2017-12-31 0.58% ₩5.49 Billion
≈ $3.72 Million
₩938.78 Billion
≈ $636.20 Million
+0.21pp
2010-12-31 0.38% ₩3.89 Billion
≈ $2.63 Million
₩1.03 Trillion
≈ $697.86 Million
+0.34pp
2009-12-31 0.03% ₩312.36 Million
≈ $211.68K
₩895.44 Billion
≈ $606.83 Million
-0.10pp
2008-12-31 0.14% ₩1.15 Billion
≈ $781.98K
₩838.43 Billion
≈ $568.19 Million
-0.13pp
2007-12-31 0.26% ₩1.82 Billion
≈ $1.23 Million
₩690.20 Billion
≈ $467.74 Million
-0.15pp
2006-12-31 0.42% ₩2.18 Billion
≈ $1.48 Million
₩525.55 Billion
≈ $356.16 Million
+0.30pp
2005-12-31 0.12% ₩478.43 Million
≈ $324.22K
₩408.94 Billion
≈ $277.13 Million
-1.36pp
2004-12-31 1.48% ₩5.40 Billion
≈ $3.66 Million
₩364.87 Billion
≈ $247.27 Million
-0.55pp
2003-12-31 2.03% ₩6.66 Billion
≈ $4.52 Million
₩327.82 Billion
≈ $222.16 Million
-0.61pp
2002-12-31 2.64% ₩8.07 Billion
≈ $5.47 Million
₩305.50 Billion
≈ $207.04 Million
-0.82pp
2001-12-31 3.46% ₩10.24 Billion
≈ $6.94 Million
₩295.82 Billion
≈ $200.48 Million
+0.90pp
2000-12-31 2.56% ₩6.32 Billion
≈ $4.28 Million
₩247.17 Billion
≈ $167.50 Million
--
pp = percentage points

About Hanmi Science

KO:008930 Korea Medical Distribution
Market Cap
$1.73 Billion
₩2.55 Trillion KRW
Market Cap Rank
#6806 Global
#187 in Korea
Share Price
₩37700.00
Change (1 day)
-0.79%
52-Week Range
₩28500.00 - ₩51900.00
All Time High
₩138933.39
About

Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult's bowel preparation and cold medicines, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment. In addition… Read more